Lymphatic Fibroblast Development Factor Molecular Variants in Newborn Diagnoses
Received Date: Jun 01, 2023 / Published Date: Jun 30, 2023
Abstract
Lymphoid fibroblast development factors are essential for blood vessels and angiogenesis due to their role in endothelial cell proliferation and migration. Fibroblasts, as vascular growth factors, are a hallmark of cancer, and associations between genetic polymorphisms and neoplasia have been extensively studied in the adult population.Regarding the neonatal population, few studies have attempted to establish associations between FIBROBLAST polymorphisms and neonatal pathologies, especially those associated with late complications. Our aim was to review the literature on FIBROBLAST polymorphisms and neonatal morbidity. A systematic search was first conducted in December 2022. The PubMed platform was used to survey MEDLINE and PubMed Central (2000-2022) by applying search strings. A PubMed search returned 62 documents. (Low birth weight or preterm infants, heart disease, lung disease, eye disease, brain disease, gastrointestinal disease). FIBROBLAST polymorphisms appear to be associated with neonatal pathologies. FIBROBLAST and FIBROBLAST polymorphisms have been implicated in retinopathy of prematurity.
Citation: Perera M (2023) Lymphatic Fibroblast Development Factor MolecularVariants in Newborn Diagnoses. Neonat Pediatr Med 9: 319. Doi: 10.4172/2572-4983.1000319
Copyright: © 2023 Perera M. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Conferences
Toronto, Canada
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 587
- [From(publication date): 0-2023 - Mar 09, 2025]
- Breakdown by view type
- HTML page views: 501
- PDF downloads: 86